FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2765987519> ?p ?o ?g. }

• W2765987519 endingPage "219" @default.
• W2765987519 startingPage "209" @default.
• W2765987519 abstract "Most of the RSV-neutralizing activity in human serum is conferred by antibodies that specifically bind to prefusion F. The RSV-neutralizing activity of an antibody correlates with its affinity for prefusion F. The epitope of F-binding antibodies is often not restricted to one site. An increasing number of RSV F-specific monoclonal antibodies have been described, a few of which even neutralize closely related pneumoviruses. Human respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in the very young. The RSV fusion protein (F) is essential for virus entry because it mediates viral and host membrane fusion. During this fusion process F is converted from a metastable prefusion conformation into an energetically favored postfusion state. Antibodies that target F can prevent viral entry and reduce disease caused by RSV. During recent years, many prefusion F-specific antibodies have been described. These antibodies typically have stronger RSV-neutralizing activity compared to those that also bind F in the postfusion conformation. Here, we describe how F-specific antibodies protect against RSV and why specifically targeting prefusion F could have great clinical potential. Human respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in the very young. The RSV fusion protein (F) is essential for virus entry because it mediates viral and host membrane fusion. During this fusion process F is converted from a metastable prefusion conformation into an energetically favored postfusion state. Antibodies that target F can prevent viral entry and reduce disease caused by RSV. During recent years, many prefusion F-specific antibodies have been described. These antibodies typically have stronger RSV-neutralizing activity compared to those that also bind F in the postfusion conformation. Here, we describe how F-specific antibodies protect against RSV and why specifically targeting prefusion F could have great clinical potential." @default.
• W2765987519 created "2017-11-10" @default.
• W2765987519 creator A5002770448 @default.
• W2765987519 creator A5014406644 @default.
• W2765987519 creator A5070224625 @default.
• W2765987519 creator A5089822643 @default.
• W2765987519 date "2018-03-01" @default.
• W2765987519 modified "2023-10-17" @default.
• W2765987519 title "Clinical Potential of Prefusion RSV F-specific Antibodies" @default.
• W2765987519 cites W1921480186 @default.
• W2765987519 cites W1966517204 @default.
• W2765987519 cites W1972940026 @default.
• W2765987519 cites W1985136634 @default.
• W2765987519 cites W1986189079 @default.
• W2765987519 cites W1988459634 @default.
• W2765987519 cites W1989501142 @default.
• W2765987519 cites W1996970629 @default.
• W2765987519 cites W2001683849 @default.
• W2765987519 cites W2004663239 @default.
• W2765987519 cites W2008001643 @default.
• W2765987519 cites W2019706667 @default.
• W2765987519 cites W2028941141 @default.
• W2765987519 cites W2031276907 @default.
• W2765987519 cites W2034621155 @default.
• W2765987519 cites W2040299410 @default.
• W2765987519 cites W2043056303 @default.
• W2765987519 cites W2048667487 @default.
• W2765987519 cites W2065401799 @default.
• W2765987519 cites W2069639522 @default.
• W2765987519 cites W2080622544 @default.
• W2765987519 cites W2093529351 @default.
• W2765987519 cites W2094048920 @default.
• W2765987519 cites W2096922886 @default.
• W2765987519 cites W2102247672 @default.
• W2765987519 cites W2102553812 @default.
• W2765987519 cites W2106930670 @default.
• W2765987519 cites W2116344658 @default.
• W2765987519 cites W2119850418 @default.
• W2765987519 cites W2124724968 @default.
• W2765987519 cites W2125065061 @default.
• W2765987519 cites W2126114330 @default.
• W2765987519 cites W2127951127 @default.
• W2765987519 cites W2133963352 @default.
• W2765987519 cites W2140898182 @default.
• W2765987519 cites W2142073032 @default.
• W2765987519 cites W2143237309 @default.
• W2765987519 cites W2152269583 @default.
• W2765987519 cites W2159725619 @default.
• W2765987519 cites W2161025464 @default.
• W2765987519 cites W2164992622 @default.
• W2765987519 cites W2167981735 @default.
• W2765987519 cites W2178271040 @default.
• W2765987519 cites W2190300929 @default.
• W2765987519 cites W2198743132 @default.
• W2765987519 cites W2223009545 @default.
• W2765987519 cites W2270869679 @default.
• W2765987519 cites W2321530544 @default.
• W2765987519 cites W2330176961 @default.
• W2765987519 cites W2338102897 @default.
• W2765987519 cites W2339488556 @default.
• W2765987519 cites W2415491485 @default.
• W2765987519 cites W2465525754 @default.
• W2765987519 cites W2497835434 @default.
• W2765987519 cites W2518435604 @default.
• W2765987519 cites W2525010336 @default.
• W2765987519 cites W2562476421 @default.
• W2765987519 cites W2563378637 @default.
• W2765987519 cites W2580797815 @default.
• W2765987519 cites W2582217477 @default.
• W2765987519 cites W2593076788 @default.
• W2765987519 cites W2599718514 @default.
• W2765987519 cites W2606445530 @default.
• W2765987519 cites W2611361909 @default.
• W2765987519 cites W4292315834 @default.
• W2765987519 doi "https://doi.org/10.1016/j.tim.2017.09.009" @default.
• W2765987519 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29054341" @default.
• W2765987519 hasPublicationYear "2018" @default.
• W2765987519 type Work @default.
• W2765987519 sameAs 2765987519 @default.
• W2765987519 citedByCount "40" @default.
• W2765987519 countsByYear W27659875192018 @default.
• W2765987519 countsByYear W27659875192019 @default.
• W2765987519 countsByYear W27659875192020 @default.
• W2765987519 countsByYear W27659875192021 @default.
• W2765987519 countsByYear W27659875192022 @default.
• W2765987519 countsByYear W27659875192023 @default.
• W2765987519 crossrefType "journal-article" @default.
• W2765987519 hasAuthorship W2765987519A5002770448 @default.
• W2765987519 hasAuthorship W2765987519A5014406644 @default.
• W2765987519 hasAuthorship W2765987519A5070224625 @default.
• W2765987519 hasAuthorship W2765987519A5089822643 @default.
• W2765987519 hasConcept C103038307 @default.
• W2765987519 hasConcept C140704245 @default.
• W2765987519 hasConcept C159047783 @default.
• W2765987519 hasConcept C159654299 @default.
• W2765987519 hasConcept C195616568 @default.
• W2765987519 hasConcept C203014093 @default.
• W2765987519 hasConcept C2522874641 @default.

• next